ArticleScience advances2026

BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares.

Xiaoyu Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.